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Dear Editor,
Delftia tsuruhatensis is a gram-negative bacillus that was first 
isolated from activated sludge collected from a domestic waste-
water treatment plant in Tsuruhata, Japan [1]. The bacteria are 
motile, slightly curved, and short rods. The species is closely re-
lated to and often misidentified as Delftia acidovorans (formerly 
Comamonas acidovorans) in biochemical tests because of their 
shared characteristics [1, 2]. However, the original D. tsuruha-
tensis isolate cannot utilize D-mannitol, whereas most D. ac-
idovorans strains can [3]. We present the first report of an 
IMP-1 metallo-β-lactamase (MBL)-producing D. tsuruhatensis 
strain that was isolated from a clinical specimen. The Institu-
tional Review Board of the CHA Bundang Medical Center, Seong-
nam, Korea, approved this study (approval number: 2020-04-
011-001) and waived the need for informed consent.
D. tsuruhatensis is typically susceptible to carbapenem [2, 4]; 
however, we isolated a carbapenem-resistant strain from a 
65-yr-old man diagnosed as having stomach cancer who under-
went total gastrectomy. On post-operative day 16, bacterial cul-
ture was performed because of onset of fever. A Delftia species 
(strain CRS1243) was isolated from the surgical drainage fluid. 
The isolate was identified as D. acidovorans with 99% probabil-
ity using Vitek 2 GN cards (bioMérieux, Marcy-l’Étoile, France) 
and with a score of 2.40 using the MALDI Biotyper (Bruker Dal-
tonics, Billerica, MA, USA). However, as the isolated bacteria 
were unable to metabolize D-mannitol, we performed 16S rRNA 
gene sequencing and identified the strain as D. tsuruhatensis 
(100% identity with GenBank accession number HQ731453.1). 
The isolate was suspected to produce carbapenemases 
based on routine antimicrobial susceptibility testing using Vitek 
AST N212 cards (bioMérieux). Antimicrobial susceptibility was 
determined according to the CLSI Minimum Inhibitory Concen-
tration (MIC) Interpretive Standards for other non-Enterobacteri-
aceae using the broth microdilution method [5, 6]. The isolate 
was not susceptible to amikacin (MIC > 64 µg/mL), levofloxacin 
(8 µg/mL), ceftazidime (>16 µg/mL), cefepime (>32 µg/mL), 
ceftriaxone (>32 µg/mL), and meropenem (16 µg/mL), but it 
was susceptible to piperacillin-tazobactam (16 µg/mL) and mi-
nocycline (≤0.5 µg/mL). The modified Hodge test result was 
positive, and in carbapenemase inhibition testing (Rosco Diag-
nostica A/S, Taastrup, Denmark), we observed enlarged inhibi-
tion zones when using disks containing meropenem supple-
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Table 1. Primers used for the PCR analysis of metallo-β-lactamase 
genes and primer walking
Primer Sequence (5´→3´) References
NDM-F1 GCC CAA TAT TAT GCA CCC GG This study
NDM-R CGG AAT GGC TCA TCA CGA TC This study
SPM-NF TGC GGG AGC GCC ATT GTC TG This study
SPM-NR TTC CAC CCG TGC CGT CCA AA This study
VIM-F GAT GGT GTT TGG TCG CAT A 7
VIM-R CGA ATG CGC AGC ACC AG 7
IMP-F GGA ATA GAG TGG CTT AAY TCT C 7
IMP-R CCA AAC YAC TAS GTT ATC T 7
SIM-F TAC AAG GGA TTC GGC ATC G 7
SIM-R TAA TGG CCT GTT CCC ATG TG 7
GIM-F TCG ACA CAC CTT GGT CTG AA 7
GIM-R AAC TTC CAA CTT TGC CAT GC 7
INT1-5CS GGC ATC CAA GCA GCA AGC 8
intl1-1F ACA TGC GTG TAA ATC ATC GTC G 9
attI-R CTT TGT TTT AGG GCG ACT GC This study
aac6-F1 GCT CGT TGA GAT GCT GTT CA This study
aacA7-R GAA GCA GCG TAC TTG AGC AA This study
IMP-1R CCT TTA ACC GCC TGC TCT AAT G 10
IMP14 AGG CGT GCT GCT GCA ACG ACT TGT 11
qacEd1-R TGA GCC CCA TAC CTA CAA AGC 9
qacE2-R ATT TGA GTG TCA GCG ACA GG This study
TniR-1 GTG TTC GGT ATT TTT GCC GC This study
TniR-2 GTA ATC CCG AGT TCT TCG CA This study
TniQ-1 TGT GGT TTC GAC TTC TTC GC This study
TniQ-2 GAC CAG AAT AGC TTT GCC TG This study
TniQ-1M TGT GGT TTC GAC TGC TAC GC This study
TniB-1 GGA AAT GGA GCA ACT GGC T This study
TniB-2 TTT CCA ACT GGT CAT CGG AG This study
TniB-1M AGA AAT GGA ACA ACT GGC G This study
TniA-1 TAG AGC GCT GGC TCA CAT T This study
TniA-2 GGA TGT GGT CGA TGA CAA AG This study
Fig. 1. Schematic representation of the 8,846-bp partial DNA sequence of the class 1 integron containing blaIMP-1 within a Tn402-like mod-








































mented with dipicolinic acid, indicating production of MBL. An 
expanded inhibition zone was also detected with disks contain-
ing meropenem supplemented with cloxacillin, but not with 
those containing boronic acid. Moreover, the cefoxitin-Hodge 
test result was negative. Based on these results, we concluded 
that this isolate was negative for AmpC β-lactamase activity.
Multiplex PCR was performed to detect the specific MBL. The 
specific primer pairs for the detection of the New Delhi MBL 
and São Paulo MBL were designed in this study and those for 
the detection of Verona integron-encoded MBL, imipenemase 
(IMP), Seoul IMP, and German IMP were selected from a previ-
ous report (Table 1). The sequence of the bacterial integron car-
rying the MBL-encoding gene was identified using primer walk-
ing (Table 1). We found that D. tsuruhatensis CRS1243 har-
bored a gene encoding blaIMP-1 within a class 1 integron located 
on a Tn402-like transposon. Between the 5'-conserved segment 
and the tni module, the gene cassettes included orfE, aac(6')-
31-like, orfE, orfE, aac(6')-II, aacA7, blaIMP-1, aacA7, aac(6')-II, 
and qacE2 (Fig. 1). The nucleotide sequence of the class 1 in-
tegron has been deposited in GenBank under accession num-
ber KC170993. While a class 3 integron has been previously 
identified in a D. tsuruhatensis strain, the gene cassettes were 
not evaluated functionally [12]. To determine the location of the 
class 1 integron, we performed plasmid extraction and conjuga-
tion [13]. However, we could not identify the band correspond-
ing to the plasmid DNA, and the carbapenem resistance was 
not transferred to sodium azide-resistant Escherichia coli J53.
Cases of human infection with D. tsuruhatensis are rare [2]. 
In 2011, D. tsuruhatensis was identified as the etiologic agent of 
a human catheter-related infection; since then, it has also been 
associated with other human infections [2]. Recently, Fenollar, 
et al. [4] identified D. tsuruhatensis as an emerging opportunis-
tic pathogen that should be considered as a cause of infection 
in patients with underlying disease and those using intravascu-
lar devices. The D. tsuruhatensis strain identified in this study 
was isolated twice in five days from pure cultures from surgical 
drainage fluid. Treatment with ciprofloxacin, an empirical antibi-
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otic was started; however, piperacillin-tazobactam was adminis-
tered after confirmation of the antibiotic susceptibility results. 
The patient’s fever subsided one day after initiation of the treat-
ment. 
To the best of our knowledge, this is the first report of IMP-1 
MBL production from a D. tsuruhatensis strain. Our findings 
suggest that clinical microbiologists need to be aware of D. tsu-
ruhatensis as a potential cause of opportunistic infections. We 
note that the blaIMP-1 gene linked to a mobile element might 
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